8 reasons the market isn't worse
8 reasons the market isn't worse

Stocks should be crushed by global turmoil, Jim Cramer says. Instead, they're doing fine.

VIDEO ON MSN MONEY

The markets slumped even after the European Central Bank moved forcefully.

By Jim J. Jubak Dec 8, 2011 5:24PM
Image: Europe (© Photodisc/SuperStock)Mario Draghi and the European Central Bank Thursday delivered everything investors could have reasonably hoped for -- and still financial markets tumbled. The German DAX Index finished the day down 2% and the Standard & Poor’s 500 Index ($INX) closed down 2.1%.

I think that market action amounts to a great big vote of no confidence in the European political leaders that have just begun a summit meeting that wraps up Friday.

At Thursday's meeting in Frankfurt, the European Central Bank cut its benchmark interest rate by 0.25 percentage points to 1%, extended the term of its credit facility for banks to three years from the current one-year term, and loosened its standards on the kinds of collateral it will accept from banks.
 

The payout isn't much, but it's the first from the automaker since 2006.

By Benzinga Dec 8, 2011 5:08PM

Image: Money (© Creatas/PictureQuest)By Jay Wong, Benzinga Staff Writer


Ford (F) said Thursday it has reinstated a quarterly dividend on its stock, and plans to pay out 5 cents per share on a quarterly basis.


The dividend will be the first from the company since 2006, when it faced significant financial difficulties and was forced to take large private loans to keep itself afloat. The decision paid off, as the company's perception seems to be better than competitors General Motors (GM) and Chrysler -- two companies that needed taxpayer loans to prevent outright collapse.

 

The acquisition is a vote of confidence in Isis Pharmaceuticals' drug development technology.

By TheStockAdvisors Dec 8, 2011 4:48PM
Image: Surgery (© Corbis)By John McCamant, The Medical Technology Stock Letter

Isis Pharmacauticals' (ISIS) baby is going to a new home. Pfizer (PFE) is acquiring Excaliard Pharmaceuticals, an Isis spinoff out of Carlsbad, Calif.

Excaliard was founded in 2006 with technology from Isis. This is an excellent example of an Isis satellite partnership program in which it licenses out drug development candidates it doesn't have the internal resources to develop.  
Tags: ISISPFE

Most of the magazine's picks will sound familiar to investors -- and there's a reason for that.

By Kim Peterson Dec 8, 2011 4:25PM
Image: Dice on stock listings (© Kate Kunz/CorbisFortune magazine has released its top 10 stock picks for 2012, and most of the names aren't new.

From Apple (AAPL) to Caterpillar (CAT), the picks rely on stable income stocks that Fortune says are undervalued. "Times are uncertain," the magazine says. "Stocks are moving in lockstep. Reliability and income matter more than ever."

When stocks move in lockstep, it's very difficult to pick ones that can rise above the rest of the action. Did Fortune make the right choices? Let's go through the picks: 

Winter is the strong period for agricultural chemical stocks, and 2 industry leaders are showing favorable entry points.

By MoneyShow.com Dec 8, 2011 3:09PM

Image: Combines in field (© Mark Karrass/Corbis/Corbis)By Tom Aspray, MoneyShow.com


As discussed in "The Four Key Seasonal Trends for 2012," research has indicated that many markets show repeating seasonal tendencies. While these tendencies do not necessarily determine price behavior, buying technically strong markets during strong seasonal periods can give traders and investors an additional edge.


As the charts show, this is the peak season for fertilizer and agricultural chemical stocks, and the weekly bottoming action in two of the key fertilizer stocks makes the risk favorable on new long positions.

 
Tags: AGUMOS

Changes in the business model appear to be paying off for the online retailing and auctioneering giant.

By InvestorPlace Dec 8, 2011 2:48PM

By Anthony John Agnello, Consumer and Technology Writer


(© Tom Grill/Corbis)Don't call it a comeback -- eBay (EBAY) has been here for a long time. But the online auctioneer and e-tailer is on the uptick again, and this time, it could stick.


Raymond James analyst Aaron Kessler's upgrade of eBay to "strong buy" gave the stock a 4% bump Monday and it was hanging onto those gains Tuesday. Kessler gave the company a 12-month price target of $39 -- a hefty 25% above current valuations. EBay is currently hovering below its resistance point price of $31.18 (trading midday Thursday at $30.97), having fluctuated between $29 and $33 for months now.

 

The insurer announced the acquisition of a leading health data analytics provider.

By Zacks.com Dec 8, 2011 1:35PM

Humana(© Creatas/SuperStock)(HUM) announced the acquisition Wednesday of health care analytics company Anvita Health. The financial terms of the deal remain undisclosed.


Anvita, established in San Diego in 2000, analyzes vast amounts of health care data to provide information to help companies improve the quality of their services and reduce costs.


The acquisition is expected to strengthen Humana’s clinical management.

 
Tags: AETHUMWLP

The burger chain's comparable global sales blew away analyst expectations for November.

By Jonathan Berr Dec 8, 2011 12:28PM
Forget Ronald McDonald. A better mascot for McDonald's (MCD) may be the Energizer Bunny, because the burger chain keeps going and going.

The Home of the Golden Arches reported that global same-store sales increased 7.4% in November, surpassing the 4.6% gain Wall Street analysts expected. Sales in Europe and the U.S. rose 6.5% each, beating analysts' expectations. Not surprisingly, shares of the Oakbrook, Ill. company, which have risen more than 25% this year, rose 1.4% to $97.75 Thursday morning. 
Tags: MCD

Expedia, Philip Morris and Las Vegas Sands are downgraded to 'neutral.'

By MSN Money Partner Dec 8, 2011 12:23PM
Information provided by Theflyonthewall.com

Thursday's noteworthy upgrades include:
  • Madison Square Garden (MSG) upgraded to Overweight from Underweight at Morgan Stanley
  • Pacific Sunwear (PSUN) upgraded to Neutral from Underweight at Piper Jaffray
  • Wipro (WIT) upgraded to Buy from Neutral at BofA/Merrill
  • Mobile TeleSystems (MBT) upgraded to Buy from Neutral at BofA/Merrill
 

Few things are as bullish as stocks breaking above the ranges they have traded in, and big-cap names like McDonald's and IBM are hitting levels we’ve never seen before.

By Jim Cramer Dec 8, 2011 10:46AM

the streetImage: Arrow Up (© Nicholas Monu/iStock Exclusive/Getty Images)Breakout!

 

Sometimes it hits you like that. You will be watching the ticker go by and you will say, "Holy cow, did I just see a 4 handle on Home Depot (HD)?" Or, "Wait a second, did McDonald's (MCD) just take out $95? Is Verizon (VZ) finally out of the $35 orb? IBM (IBM) about to take out $200? No way!"

 

That's where we are right now: Stocks are hitting levels we haven't seen before -- not "haven't seen in a while" . . . never before.

 

CEO Jeff Bezos is focused on a far-reaching strategy, rather than just short-term results.

By TheStockAdvisors Dec 8, 2011 9:46AM
Photodisc/SuperStockBy David Sandell, Leeb's Income Performance Letter

Amazon.com (AMZN) has been making massive investments in its future at the expense of short-term results.

With Jeff Bezos -- one of the few remaining tech visionaries -- at the helm, we’re willing to bet the online retailer will succeed in its far-reaching strategy. 
Tags: AMZN

The biopharmaceutical company's core product strategy is aimed at addressing major unmet medical needs.

By Zacks.com Dec 7, 2011 8:09PM
We have maintained an "outperform" rating on Alnylam Pharmaceuticals (ALNY) with a target price of $8.25 per share following the biopharmaceutical company's third-quarter results.


Alnylam develops therapeutics based on a biological breakthrough technology known as ribonucleic acid interference (RNAi). Alnylam is currently using this know-how to build a pipeline of drug candidates to treat a wide array of diseases.

 

Federal regulators nix a proposal to make the pill available without a prescription to minors.

By Benzinga Dec 7, 2011 6:09PM

By Phil Marsh, Benzinga Staff Writer


Teva Pharmaceutical (TEVA) hoped to have the first over-the-counter emergency contraceptive available to all ages Wednesday. It failed.


The U.S. Department of Health and Human Services rejected the company's application for Plan B One-Step -- known as the original morning-after pill -- to be available to consumers of all ages without a prescription. A positive verdict would have given Teva an exclusivity advantage it lost back in 2009, when a generic version of its drug hit the market.

 

The company reportedly is considering an online marketplace and fast-shipping service that may compete with Amazon.

By Trefis Dec 7, 2011 5:48PM
Image: Senior woman working from home © Alistair Berg/Digital Vision/Getty ImagesGoogle (GOOG) isn't done with its online commerce initiatives yet.

The search giant is reportedly in negotiations with major retailers and shippers to create an online marketplace, taking Amazon (AMZN) head on. If Google's service manages to launch, it would directly compete against Amazon Prime, which provides customers free and quick shipping for a fixed annual fee.

Given the spate of new initiatives at Google, we believe the fast-shipping service will be a little more difficult to tackle, and question whether the company has the stomach for a business that could be very difficult. 

The $100 million stake in Brazil's No. 2 airline will give Delta a way to win share in Latin America.

By Jim J. Jubak Dec 7, 2011 5:16PM
Image: Airline (© Christie & Cole/Corbis)Delta Air Lines (DAL) announced Wednesday an agreement to buy a $100 million minority position in Brazil’s Gol Linhas Aereas Inteligentes (GOL). 

The agreement would give Gol, Brazil’s second-biggest airline, a counter to the hookup of larger rival Tam (TAM) with Lan Airlines (LFL), Latin America’s largest airline. And it would give Delta a way to win market share in Latin America, a market where it trails American Airlines and United Continental Holdings (UAL).

Gol’s U.S.-traded ADRs (American depositary receipts) were up 5.5% at market close Wednesday. (Gol is a member of my Jubak Picks 50 long-term portfolio.)
 
Tags: amrDALual

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

133
133 rated 1
286
286 rated 2
441
441 rated 3
737
737 rated 4
614
614 rated 5
606
606 rated 6
621
621 rated 7
441
441 rated 8
317
317 rated 9
122
122 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
BBBYBED BATH & BEYOND INC10
TWXTIME WARNER Inc10
COPCONOCOPHILLIPS9
HDHOME DEPOT Inc9
VZVERIZON COMMUNICATIONS9
More

Trending NOW

What’s this?

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market capped the trading week with losses across the major averages. The S&P 500 fell 0.5% to surrender its weekly gain, while the Dow Jones Industrial Average (-0.7%) and Russell 2000 (-0.9%) underperformed. The two indices posted respective losses of 0.8% and 0.6% for the week.

Equity indices were pressured from the get-go after several heavyweights disappointed the market with their earnings and/or guidance, which led to some broader profit-taking. After ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.